Alembic Pharmaceuticals Ltd's Bioequivalence facility located at Baroda was inspected by US Food & Drug Administration (FDA) between 6th March, 2017 & 10th March, 2017, between 13th March, 2017 & 17th March, 2017 and between 10th April, 2017 to 12th April, 2017 for a) Bioequivalence Clinical
b) Bioequivalence Bioanalytical
There were no 483s issued by US FDA at the end of the inspection.
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.609.8 as compared to the previous close of Rs. 624.6. The total number of shares traded during the day was 32396 in over 1326 trades.
The stock hit an intraday high of Rs. 645.05 and intraday low of 607.5. The net turnover during the day was Rs. 20310484.